Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/43239
Title: Edoxaban and/or colchicine for patients with coronavirus disease 2019 managed in the out-of-hospital setting (CONVINCE): a randomized clinical trial
Authors: Landi, Antonio
Morici, Nuccia
VRANCKX, Pascal 
Frigoli, Enrico
Bonacchini, Luca
Omazzi, Barbara
Tresoldi, Moreno
Camponovo, Claudio
Moccetti, Tiziano
Windecker, Stephan
Valgimigli, Marco
Issue Date: 2024
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Source: Journal of Cardiovascular Medicine, 25 (7) , p. 565 -568
Abstract: Medtronic, Novartis, Polares, Sinomed, Terumo, V-Wave and Xeltis, but has not received personal payments by pharmaceutical companies or device manufacturers. He is also member of the steering/executive committee group of several investigator-initiated trials that receive funding by industry without impact on his personal remuneration. M.V. reports grants and/or personal fees from
Notes: Valgimigli, M (corresponding author), Cardioctr TicinoInstitute, Ente Ospedaliero Cantonale, Via Tesserete 48, CH-6900 Lugano, Switzerland.
marco.valgimigli@eoc.ch
Keywords: colchicine;coronavirus disease 2019;edoxaban;severe acute respiratory syndrome coronavirus 2
Document URI: http://hdl.handle.net/1942/43239
ISSN: 1558-2027
e-ISSN: 1558-2035
DOI: 10.2459/JCM.0000000000001639
ISI #: 001237520200012
Rights: 2024 Italian Federation of Cardiology - I.F.C. All rights reserved.
Category: A1
Type: Journal Contribution
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
zz.pdf
  Until 2025-01-01
Peer-reviewed author version605.85 kBAdobe PDFView/Open    Request a copy
Show full item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.